Is Schrodinger Inc (SDGR) overvalued? · rev $207.5M
Schrodinger Inc (SDGR) is a health information services company listed on NASDAQ.
This page asks whether Schrodinger Inc (SDGR) looks expensive on cached numbers — not a short thesis.
Latest reported SDGR revenue for 2024-12-31 was $207.5M. Net income was -$187.1M. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. SDGR currently screens at market cap $1.16B.
SDGR currently screens at market cap $1.16B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SDGR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SDGR stock page for the full model, not this heading.
Not investment advice.